Chu S.-Y.Chien C.-C.WUH-LIANG HWUWang P.-J.YIN-HSIU CHIEN2020-12-162020-12-1620201079-9796https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077303111&doi=10.1016%2fj.bcmd.2019.102402&partnerID=40&md5=31abefc32ccf67af17a8b075a029a67ehttps://scholars.lib.ntu.edu.tw/handle/123456789/525778[SDGs]SDG3ambroxol; imiglucerase; ambroxol; clinical article; combination drug therapy; drug megadose; enzyme replacement; female; Gaucher disease; human; infant; Letter; newborn; priority journal; case report; combination drug therapy; enzyme replacement; Gaucher disease; procedures; time to treatment; treatment outcome; Ambroxol; Drug Therapy, Combination; Enzyme Replacement Therapy; Gaucher Disease; Humans; Infant; Time-to-Treatment; Treatment OutcomeEarly initiation of high-dose oral ambroxol in combination with enzyme replacement therapy in a neuropathic Gaucher infantletter10.1016/j.bcmd.2019.102402319183842-s2.0-85077303111